Search for: "Novartis Pharmaceuticals Corp."
Results 101 - 120
of 366
Sorted by Relevance
|
Sort by Date
5 Dec 2011, 8:59 am
SmithKline Beecham Corp., for example, rejected the argument that pharmaceutical sales representatives did not qualify for the Outside Sales exemption. [read post]
2 Feb 2012, 6:28 am
SmithKlineBeecham Corp., which involves the same issue of whether the FLSA's outside sales exemption applies to pharmaceutical representatives. [read post]
30 May 2011, 7:34 am
Novartis Pharmaceuticals Corp., No. 06-Civ-260 (BMC) (EDNY), and we’ve got some good news to report. [read post]
12 Jul 2010, 4:29 pm
Schering Corp., 2010 WL 2669304 (2nd Cir., July 06, 2010), the Court affirmed a District Court order denying the defendant's motion for summary judgment on the outside sales exemption. [read post]
18 Nov 2010, 9:56 am
A new report by the Washington Times shows that Novartis Pharmaceutical Corp. paid more than $3.6 million in fees to top sports figures such as New York Giants quarterback Eli Manning and Baseball Hall-of-famer Bob Gibson between 2006 and 2009. [read post]
31 Jul 2018, 9:06 am
We have talked about the FDA’s approval of tisagenlecleucel (KYMRIAH, Novartis Pharmaceuticals Corp.), a CD19-directed genetically modified autologous T-cell immunotherapy, to include treatment of patients with relapsed or refractory large B-cell lymphoma. [read post]
27 May 2011, 10:24 am
Novartis Pharmaceuticals Corp, which was pending in the U.S. [read post]
21 May 2012, 9:33 pm
Orion Corp. v. [read post]
5 Dec 2011, 8:59 am
SmithKline Beecham Corp., for example, rejected the argument that pharmaceutical sales representatives did not qualify for the Outside Sales exemption. [read post]
2 Jun 2011, 3:22 pm
Novartis Pharmaceuticals Corp. v. [read post]
26 Jun 2016, 3:31 am
Corp. [read post]
3 Jan 2011, 5:49 am
Novartis Pharmaceuticals Corp., 2010 MT 282 (Montana December 30, 2010), adds to this Winter of discontent. [read post]
16 Jun 2021, 1:30 pm
New Jersey Tasigna Multi-county Litigation (MCL), Federal Court Tasigna Multidistrict Litigation (MDL) (Posted by Tom Lamb at Drug Injury Watch) In early June 2021, the New Jersey Supreme Court consolidated Tasigna drug injury lawsuits filed against Novartis Pharmaceuticals Corp. before one judge for pretrial proceedings as part of a New Jersey state court multi-county litigation (MCL). [read post]
16 Oct 2006, 7:58 pm
Novartis sued Par Pharmaceuticals, the third and most recent company to file an ANDA for generic Lotrel. [read post]
26 Feb 2010, 4:17 pm
Novartis Pharmaceuticals Corp.; Simonian v. [read post]
19 Jun 2012, 11:30 am
Novartis Pharmaceuticals Corp., No. 11-5053 (6th Cir., 6/5/12). [read post]
7 Oct 2010, 12:19 pm
Novartis Pharmaceuticals Corp. found in favor of the Defendant and against Jane Bessemer, who alleged she developed osteonecrosis of the jaw (ONJ) as a result of using Aredia and, thereafter, Zometa, two bisphosphonate drugs made by Novartis. [read post]
28 Apr 2013, 9:32 am
According to DOJ’s complaint: The Justice Department announced today that the United States has filed a second civil false claims lawsuit against Novartis Pharmaceuticals Corp. involving alleged kickbacks paid by the company to health care providers. [read post]
25 Jun 2012, 1:32 pm
Novartis Pharmaceuticals Corp., ___ F.R.D. ___, 2012 WL 2354451 (W.D. [read post]
25 Apr 2013, 5:02 pm
Novartis Didn't Properly Test Hypertension Drugs, Suit Says, Law 360, April 16, 2013 Valturna, FDA More Blog Posts:Products Liability Claims in Pelvic Mesh Lawsuit Against Boston Scientific Corp. [read post]
